In conclusion, our findings from in silico analyses and in vitro experiments shed new light on the involvement of vitronectin to the pathogenesis of AMD and suggest a vitronectin- and PAI-1-dependent biological mechanism, possibly promoting the neovascular complications seen in NV-AMD. The gene discussed is VTN; the disease is age-related macular degeneration.